C

CareDx
D

CDNA

23.140
USD
0.55
(2.43%)
Market Closed
Volume
44,954
EPS
-1
Div Yield
-
P/E
-9
Market Cap
1,241,087,775
Related Instruments
    A
    ACU
    -0.660
    (-1.56%)
    41.730 USD
    B
    BCRX
    -0.41500
    (-5.57%)
    7.03500 USD
    C
    CGA
    0.12000
    (6.78%)
    1.89000 USD
    C
    CMP
    2.490
    (20.73%)
    14.500 USD
    C
    CRIS
    -0.04000
    (-1.00%)
    3.96000 USD
    C
    CTIC
    0.11000
    (2.54%)
    4.44000 USD
    N
    NTR
    -0.190
    (-0.41%)
    46.190 USD
    More
News

Title: CareDx

Sector: Healthcare
Industry: Diagnostics & Research
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.